Diagnosis and treatment of HIV-associated manifestations in otolaryngology

Infectious Disease Reports

Volumn 4, Issue 1, 2012, Pages 22-29

  Iacovou, Emily ^a   Vlastarakos, Petros V ^b   Papacharalampous, George ^c   Kampessis, George ^d   Nikolopoulos, Thomas P ^e  

^a General Hospital of Larnaca   (Cyprus)

^b LISTER HOSPITAL   (United Kingdom)

^c PENTELI CHILDREN S HOSPITAL   (Greece)

^d ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^e NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

AIDS; Ear; HIV; Nose; Oral; Throat

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CEFUROXIME; CLINDAMYCIN; CLOTRIMAZOLE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DECONGESTIVE AGENT; DOXORUBICIN; DOXYCYCLINE; FLUCONAZOLE; GLYCOLIC ACID; ITRACONAZOLE; METRONIDAZOLE; NYSTATIN; PREDNISONE; TETRACYCLINE; TRICHLOROACETIC ACID; VINCRISTINE; VORICONAZOLE;

BACTERIAL SINUSITIS; CANCER RADIOTHERAPY; CANDIDIASIS; CHEILITIS; CRYOTHERAPY; CYTOREDUCTIVE SURGERY; EAR DISEASE; EARLY DIAGNOSIS; ERYTHEMATOUS CANDIDIASIS; FACIAL NERVE PARALYSIS; GINGIVA DISEASE; GINGIVITIS; HAIRY LEUKOPLAKIA; HEAD AND NECK DISEASE; HERPETIC STOMATITIS; HIV ASSOCIATED EAR DISEASE; HIV ASSOCIATED EAR NOSE THROAT DISEASE; HIV ASSOCIATED HEAD AND NECK DISEASE; HIV ASSOCIATED NOSE DISEASE; HIV ASSOCIATED OROPHARYNGEAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LASER SURGERY; NONHODGKIN LYMPHOMA; NOSE DISEASE; OTALGIA; OTITIS MEDIA; PAPILLOMAVIRUS INFECTION; PAROTIDECTOMY; PERCEPTION DEAFNESS; PERIODONTAL DISEASE; PERIODONTITIS; PHARYNX DISEASE; REVIEW; SALIVARY GLAND DISEASE; THRUSH;

EID: 84866793730     PISSN: None     EISSN: 20367449     Source Type: Journal    
DOI: 10.4081/idr.2012.e09     Document Type: Review

References (81)

1. UNAIDS. Report on the global AIDS epidemic. 2010.
2. Baccaglini L, Atkinson JC, Patton LL, et al. Management of oral lesions in HIV-positive pacients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:S50.e1-S50e23.
3. Williams MA. Head and neck findings in pediatric acquired immune deficiency syndrome. Laryngoscope. 1987;97:713-6.
4. Prasad HK, Bhojwani KM, Shenoy V, Prasad SC. HIV manifestations in otolaryngology. Am J Otolaryngol-Head and Neck Med and Surg 2006;27:179-85.
5. Johnson NW, Glick M, Mbuguye TNL. Oral health and general health. Adv Dent Res 2006;19:118-21.
6. Tappuni AR, Flemnming GJ. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:623-8.
7. Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res 2006;19:57-62.
8. Reznik DA. Oral manifestations of HIV disease. Top HIV Med 2005;13:143-8.
9. Miziara ID, Weber R. Oral candidosis and oral hairy leukoplakia a predictors of HAART failure in Brazilian HIV-infected patients. Oral Dis 2006;12:402-7.
10. Ramirez-Amador V, Ponce-de-Leon S, Anaya-Saavedra G, et al. Oral Lesions as Clinical Markers of Highly Active Antiretroviral Therapy Failure: A Nested Case-Control Study in Mexico City. Clin Infect Dis. 2007;45:925-32.
11. Silverman Jr S, Migliorati CA, Lozada-Nur F, et al. Oral findings in people with or at high risk for AIDS: a study of 375 homosexual males. J Am Dent Assoc 1986;112:187-92.
12. Phelan JA, Saltzman BR, Friedland GH, et al. Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 1987;64:50-6.
13. Naidoo S, Chikte U. Oro-facial manifestations in paediatric HIV: a comparative study of institutionalized and hospital outpatients. Oral Dis 2004;10:13-8.
14. Cherry-Peppers G, Daniels CO, Meeks V, Sanders CF, Reznik D. Oral manifestations in the era of HAART. J Natl Med Assoc 2003; 95:21S-32S.
15. Ranganathan K, Hemalatha R. Oral lesions in HIV infection in developing countries: an overview. Adv Dent Res 2006;19:63-8.
16. Johnson NW. The mouth in HIV/AIDS: markers of disease status and management challenges for the dental profession. Australian Dent J 2010;55:85-102.
17. Pienaar ED, Young T, Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. (Cochrane Review). In: The Cochrane Library, Issue 3, Oxford, 2007: Update Software.
18. Leggott PJ, Robertson PB, Greenspan D, et al. Oral manifestations of primary and acquired immunodeficiency diseases in children. Pediatr Dent. 1987;9:98-104.
19. Ranganathan K, Reddy BV, Kumarasamy N, et al. Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients. Oral Dis 2000;6:152-7.
20. Flaitz C, Wullbrandt B, Sexton J, et al. Prevalence of orodental findings in HIVinfected Romanian children. Pediatr Dent 2001;23:44-50.
21. Lamster IB, Grbic JT, Mitchell-Lewis DA, et al. New concepts regarding the pathogenesis of periodontal disease in HIV infection. Ann Periodontol 1998;3:62-75.
22. Yeung SC. HIV infection and periodontal disease. Ann R Australas Coll Dent Surg 2000;15:331-4.
23. Glick M, Muzyka BC, Salon LM, Luric D. Necrotizing ulcerative periodontitis: a marker for severe immune deterioration. J Periodontol 1994;65:393-7.
24. Winkler JR, Robertson PB. Periodontal disease associated with HIV infection. Oral Surg Oral Med Oral Pathol 1992;73:145-50.
25. American Dental Association. Dental management of the HIV-infected patient. J Am Dent Assoc 1995;126:1-39.
26. Kline MW. Oral manifestiations of pediatric human inmunodeficiecy virus infection: a review of de la literature. Pediatrics 1996;97:380-8.
27. Wikipedia™ The free encyclopedia.
28. Santos LC, Castro GF, De Souza IP, Oliveira RH. Oral manifestations related to immunosuppresion degree in HIV-positive children. Braz Dent J 2001;12:135-8
29. Flaitz CM, Hicks MJ, Carter AB, et al. Saliva collection technique for cytologic, microbiologic and viral evaluation in pediatric HIV infection. ASDC J Dent Child 1998;65:318-24.
30. Leggott PJ. Oral manifestations of HIV infection in children. Oral Surg Oral Med Oral Pathol 1992;73:187-92.
31. Sroussi HY, Epstein JB. Changes in the pattern of oral lesionsassociated with HIV infection: Implications for dentists. JCDA 2008;73:949-52.
32. Arendorf T, Holmes H. Oral manifestations associated with human immunodeficiency virus (HIV) infection in developing countries -are there differences from developed countries?. Oral Dis 2000;6:133-5.
33. Greenspan JS, Greenspan D. The epidemiology of the oral lesions of HIV infection in the developed world. Oral Dis 2002;8:34-9.
34. Patton L, Hill C. Sensitivity, specificity, and positive predictive value of oral oppurtunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;90:182-8.
35. Nishio CE, Petri V, Narahashi E. Oral hairy leukoplakia: topical use of trichloracetic and glycolic acids -results. In: 10th International Conference on AIDS, Yokohama, Japan, 1994.
36. Gowdey G, Lee RK, Carpenter WM. Treatment of HIV-related hairy leukoplakia with podophyllum resin 25% solution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;79:64-7
37. Bartlett JG. The Johns Hopkins Hospital Guide to Medical Care of Patients with HIV Infection. 4th ed. Williams & Wilkins, Baltimore, 1994.
38. Diz Dios P, Ocampo A, Miralles C. Changing prevalence of human immunodeficiency virus-associated oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000:4034.
39. Patton LL, McKaig R, Straauss R, et al. Changing prevalence of oral manifestations of human immunodeficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90:299-304
40. Syrjänen S. Human papillomavirus infection and its association with HIV. Adv Dent Res 2011;23:84-9.
41. Leao JC, Ribeiro CMB, Carvalho AAT, et al. Oral complications of HIV disease. Clinics 2009;64:459-70.
42. Schweitzer VG, Visscher D. Photodynamic therapy for treatment of AIDS-related oral Kaposi's sarcoma. Otolaryngol Head Neck Surg J 1990;102:639-49.
43. Singh B, Lucente FE. Kaposi's sarcoma of the head and neck inpatients with acquired immunodeficiency syndrome. Otolaryngol Head Neck Surg J 1994;111:618-24.
44. Weinert M, Grimes RM, Lynch DP. Oral Manifestations of HIV Infection. Ann Intern Med 1996;125:485-96.
45. Fisher RI, Gaynor ER, Dahlberg S et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993;328:1002-6.
46. Gisselbrecht C, Spina M, Gabarre J et al. Therapy of HIV-related non-Hodgkin's lymphoma: an European multicentric randomized study in patients stratified according to their prognostic factors: preliminary results. J Acquir Immune Defic Syndr 1997;14:abstract 149.
47. Lee KC, Cheung CW. Evaluation of the neck mass in the human immunodeficiency virus- infected patients. Otolaryngol Clin North Am 1992;25:1287-305.
48. Singh A, Georgalas C, Papel N, Papesh M. ENT presentations in children with HIV infection. Clin Otolaryngol 2003;28:240-3.
49. Abrams DI. AIDS-related lymphadenopathy: the role of biopsy. J Clin Oncol 1986;4:126-7.
50. Casiano RR, Cooper JD, Gould E, et al. Value of needle biopsy directing management of parotid lesions in HIV-positive patients. Head Neck J 1991;13:411-4.
51. Beirler JJ, Vikram B, Silver CE, et al. (1995) Low-dose radiotherapy for multicystic benign lymphoepithelial lesions of the parotid gland in HIV-positive patients: Long-term results. Head Neck J 1995;17:31-5.
52. Lalwani AK, Sooy CD. Otologic and neurotologic manifestations of acquired immunodeficiency syndrome. Otolaryngol Clin North Am 1992;25:1183-97.
53. Kaplan MH, Sadick N, McNutt NS, et al. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol 1987;16:485-506.
54. Chandrasekhar SS, Siverls V, Chandra Sekhar H. Histopathologic and ultrastructural changes in the temporal bones of HIVinfected human adults. Am J Otol 1992;13:207-14.
55. Frick OL. Role of viral infections in asthma and allergy. Clinical Review in Allergy 1983;1:5-17.
56. Miziara ID, Weber R, Cunha Filho BA, Pinheiro Neto CD. Otitis media in Brazilian human immunodeficiency virus infected children undergoing antiretroviral therapy. J Laryngol Otol 2007;121:1048-54.
57. Lanser MJ, Klein ZH, Marvin A. Kaposi's sarcoma in patients with AIDS. Arch Otolaryngol 1985;111:486-9.
58. Kampessis G, Vlastarakos PV, Papanikolaou P, et al. Bilateral acute mastoiditis in an HIV-Positive patient. Skull Base 2009;19:10.
59. Newton JP. The causes of hearing loss in HIV infection. Community Ear and Hearing Health 2006;3:1-16.
60. Anders K, Guerra WF, Tomiyasu U, et al. The neuropathology of AIDS. UCLA experience and review. Am J Pathol 1986;124:537-58.
61. Kim MS, Yoon HJ, Kim HJ, et al. Bilateral peripheral facial palsy in a patient with Human Immunodeficiency Virus (HIV) infection. Med J 2006;47:745-7.
62. Belec L, Georges AJ, Vuillecard E, et al. Peripheral facial paralysis indicating HIV infection. Lancet 1988;2:1421-2.
63. Sasaki MG, Leite PGB, Leite AGB, et al. Bilateral peripheral facial palsysecondary to lymphoma in a patient with HIV/AIDS: A case report and literature review. BJID 2002; 6:50-4.
64. Abboud O, Saliba I. Isolated bilateral facial paralysis revealing AIDS: a unique presentation. Laryngoscope 2008;118:580-4.
65. Goldani LZ, da Silva LF, Dora JM Ramsay Hunt syndrome in patients infected with human immunodeficiency virus. Clin Exp Dermatol 2009;34:e552-4.
66. Chand V, Sweeney C, Agger WA. Mental neuropathy in patients with AIDS associated malignant lymphoma. Clin Inf Dis 1997;24:521-2
67. Tami TA, Wawrose S. Diseases of the nose and paranasal sinus in the acquired immunodeficiency virus-infected population. Otolaryngol Clin North Am 1992;25:1199-210.
68. Campanini A, Marani M, Mastroianni A, et al. Human immunodeficiency virus infection: personal experience in changes in head and neck manifestations due to recent antiretroviral therapies. Acta Otorhinolaryngol Ital 2005;25:30-5.
69. Sanjar FA, Queiroz BE, Miziara ID. Otolaryngologic manifestations in HIV disease--clinical aspects and treatment. Braz J Otorhinolaryngol 2011;77:391-400.
70. Miziara ID, Araujo Filho BC, La Cortina RC, et al. Chronic rhinosinusitis in HIV-infected patients: radiological and clinical evaluation. Rev Bras Otorrinolaringol 2005;7:604-8.
71. Sample S, Chernoff DN, Lenahan GA, et al. Elevated serum concentrations of IgE antibodies to environmental antigens in HIVseropositive male homosexuals. J Allergy Clin Immunol 1990;86:876-80.
72. Kedem E, Shahar E, Hassoun G, Pollack S. Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. J Asthma 2010;47:830-1.
73. HIV Insite: project of the University of California San Francisco center for HIV information. Available from: http://hivinsite.ucsf.edu.
74. Van Heeswijk RP, Bourbeau M, Campbell P, et al. (2006) Time-dependent interaction between lopinavir/ritonavir and fexofenadine. J Clin Pharmacol 2006;46:758-67
75. Been-Tiktak AM, Boucher CA, Brun-Vezinet F, et al. Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial. Int J Antimicrob Agents 1999;11:13-21.
76. Gurney TA, Lee KC, Murr AH. Contemporary issues in rhinosinusitis and HIV infection. Curr Opin Otolaryngol. Head Neck Surg 2003;11:45-8.
77. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130:1-45.
78. HIV InSite Knowledge Base. Available from: http://hivinsite.ucsf.edu/InSite?page=kb-04-01-13#S7.5X.
79. Friedman M, Landsberg R, Tanyeri H, et al. Endoscopic sinus surgery in patients with HIV. Laryngoscope 2000;110:1613-6.
80. Shah AR, Hairston JA, Tami TA. Sinusitis in HIV: Microbiology and Therapy. Current Allergy and Asthma Report 2005;5:495-9.
81. Vlastarakos PV, Manolopoulos L, Ferekidis E, et al. Treating common problems of the nose and throat in pregnancy: what is safe? Eur Arch Otorhinolaryngol 2008;265: 499-508.